Latest filing published 04 Aug 2026 for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED, €6.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Guo Min: trading record in brief
Guo Min discloses dealings in Tianjin Pharmaceutical da REN Tang Group Corporation Limited to SGX. We count 2 filings; the first trade dates from 4 February 2026 and the latest from 4 August 2026.
On the market, this insider has only ever bought: 2 purchases, €12 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 4 August 2026, the filings show an open-market purchase worth €6 in Tianjin Pharmaceutical da REN Tang Group Corporation Limited. This summary is built from SGX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Guo Min
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9 shares@ SGD 1.00ShareSGX-STISIN CNE100000924SGX:PHARI82HES0BJB02Canonical exit: 2 Nov 2026 (T+90)
1 of 1 declaration